Winton Group’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,322
| Closed | -$224K | – | 963 |
|
|
2022
Q2 | $224K | Buy |
+8,322
| New | +$224K | 0.01% | 884 |
|
|
2020
Q4 | – | Sell |
-24,180
| Closed | -$359K | – | 1339 |
|
|
2020
Q3 | $359K | Buy |
24,180
+4,779
| +25% | +$71K | 0.01% | 1197 |
|
|
2020
Q2 | $252K | Buy |
19,401
+7,374
| +61% | +$95.8K | 0.01% | 1317 |
|
|
2020
Q1 | $20K | Sell |
12,027
-20,000
| -62% | -$33.3K | ﹤0.01% | 1371 |
|
|
2019
Q4 | $71K | Sell |
32,027
-1,634
| -5% | -$3.62K | ﹤0.01% | 1498 |
|
|
2019
Q3 | $72K | Buy |
+33,661
| New | +$72K | ﹤0.01% | 1479 |
|